Business : Business Ethics

A unique and pertinent study of a very relevant topic, this volume debates the relationship between business and the environment and the future forms that this relationship can take. more...

Price: $180.00

'A very important addition to the scenarios literature. The editors and contributors ... are all to be congratulated.' The British Accounting Review 'A welcome and important addition to our field.' Paul J. H. Schoemaker PhD adjunct professor of marketing The Wharton School author of Winning Decisions Profiting from Uncertainty and Peripheral Vision 'This is a very useful book.' Yves Doz Professor of strategic management INSEAD 'Essential reading for the new generation of business leaders.' Napier Collyns cofounder of Global Business Network The world is increasingly turbulent and complex awash with disruptions tipping points and knock-on effects. These range from the impacts of warfare in the Middle East on energy futures investment and global currencies to the vast and unpredictable impacts of climate change. All this threatens established strategic planning methods. This book is for business and organizational leaders who want and need to think through how best to deal with increasing turbulence and with the complexity and uncertainty that come with it. The authors explain in clear language how future orientation and specifically modern scenario techniques help to address these conditions. They draw on examples from a wide variety of international settings and circumstances including large corporations inter-governmental organizations small firms and municipalities. Readers will be inspired to try out scenario approaches themselves to better address the turbulence that affects them and others with whom they work live and do business. A key feature of the book is the exchange of insights across the academic-practitioner divide. Scholars of scenario thinking and organizational environments will appreciate the authors' conceptual and methodological advances. What has previously remained jargon only accessible to the highest level of corporate and government futures planners here becomes comprehensible to a wider business and practi more...

Price: $77.95

The revolutionary seven dimensions that lead to sustainable business practice are identified and explored as well as the “blind-spots” that most corporate leaders have that prevent them from joining the revolution more...

Price: $11.95

It began with a promising cancer drug, the brainchild of a gifted researcher, and grew into an insider trading scandal that ensnared one of America's most successful women. The story of ImClone Systems and its ''miracle'' cancer drug, Erbitux, is the quintessential business saga of the late 1990s. It's the story of big money and cutting-edgescience, celebrity, greed, and slipshod business practices; the story of biotech hype and hope and every kind of excess. At the center of it all stands a single, enigmatic figure named Sam Waksal. A brilliant, mercurial, and desperate-to-be-liked entrepreneur, Waksal was addicted to the trappings of wealth and fame that accrued to a darling of the stock market and the overheated atmosphere of biotech IPOs. At the height of his stardom, Waksal hobnobbed with Martha Stewart in New York and Carl Icahn in the Hamptons, hosted parties at his fabulous art-filled loft, and was a fixture in the gossip columns. He promised that Erbitux would ''change oncology,'' and would soon be making $1 billion a year. But as Waksal partied late into the night, desperate cancer patients languished, waiting for his drug to come to market. When the FDA withheld approval of Erbitux, the charming scientist who had always stayed just one step ahead of bankruptcy panicked and desperately tried to cash in his stock before the bad news hit Wall Street. Waksal is now in jail, the first of the Enron-era white-collar criminals to be sentenced. Yet his cancer drug has proved more durable than his evanescent profits. Erbitux remains promising, the leading example of a new way to fight cancer, and patients and investors hope it will be available soon. more...

Price: $18.99

Elaborates the debate on corporate social responsibility, by exploring both the theoretical and practical aspects of organizing and implementing CSR within organizations. This book captures the implementation perspectives, and demonstrates the possible changes and consequences of implementing CSR. more...

Price: $116.00